Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/65760

Registo completo
Campo DCValorIdioma
dc.contributor.authorBrancato, V.por
dc.contributor.authorKundu, Bananipor
dc.contributor.authorOliveira, Joaquim M.por
dc.contributor.authorCorrelo, V. M.por
dc.contributor.authorReis, R. L.por
dc.contributor.authorKundu, Subhas Cpor
dc.date.accessioned2020-06-25T16:05:30Z-
dc.date.available2020-06-25T16:05:30Z-
dc.date.issued2020-06-
dc.date.submitted2020-06-
dc.identifier.citationBrancato V., Kundu B., Oliveira J. M., Correlo V. M., Reis R. L., Kundu S. C. Tumor - stroma interactions alter the sensitivity of drug in breast cancer, frontiers in materials, Vol. 7, pp. 116, doi:10.3389/fmats.2020.00116, 2020por
dc.identifier.issn2296-8016por
dc.identifier.urihttps://hdl.handle.net/1822/65760-
dc.description.abstractFlat cell cultures or xenografts are inadequate tools to unravel cancer complex biology. 3D in vitro tumor models garnered interest since they recapitulate better dynamic mechanisms of cancer, but a gold standardmodel that faithfullymimics solid cancer is not available yet. 3D breast cancermodel is fabricated using freeze-dried silk fibroin scaffolds. Breast cancer cell lines (MCF-7 and MDA-MB231) are seeded with normal mammary fibroblasts onto silk fibroin scaffold (1 and 2mm thick). Cells proliferation is monitored by means of Alamar blue assay. 3D breast cancer models morphology is observed by confocal microscopy. Gene expression modulation concerning extracellular matrix markers is evaluated. Further, 3D bioengineered breast cancer models are treated with doxorubicin. Silk fibroin scaffolds allow the proliferation of cancer cells and fibroblasts. Cells growth is enhanced when cancer cells and fibroblasts are seeded together. Histological staining shows 3D cell organization. MMP-1, MMP-2, MMP-3, Col-1, and Fibronectin expression is upregulated in co-culture. After doxorubicin treatment, stronger reduction in cell activity is observed in 2mm SF scaffold in comparison to 1mm. The 3D in vitro breast cancer model obtained can easily be scaled-up and translated to the preclinical testing of novel chemotherapeutics.por
dc.description.sponsorshipThis work was supported by EU-Horizon 2020 grant FoReCaST—Forefront Research in 3D Disease Cancer Modelsasin vitroScreening Technologies (H2020-WIDESPREAD-2014-668983). The authors also acknowledge the FRONTHERA project (Frontiers of technology for theranostics of cancer,metabolic and neurodegenerative diseases) (NORTE-01-0145-FEDER-0000232) and Fundação Ciência e tecnologia (FCT grantagreement: PTDC/BTM-ORG/28168/2017 to VB and SK).por
dc.language.isoengpor
dc.publisherFrontiers Mediapor
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/668983/EUpor
dc.relationPTDC/BTM-ORG/28168/2017por
dc.rightsopenAccesspor
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/por
dc.subject3D cancer modelspor
dc.subjectDrug testingpor
dc.subjectSilk Fibroinpor
dc.subjectTumor microenvironmentpor
dc.subjecttumor stromapor
dc.titleTumor - stroma interactions alter the sensitivity of drug in breast cancerpor
dc.typearticle-
dc.peerreviewedyespor
dc.relation.publisherversionhttps://doi.org/10.3389/fmats.2020.00116por
dc.commentshttp://3bs.uminho.pt/node/20306por
oaire.citationVolume7por
dc.date.updated2020-06-25T15:02:56Z-
dc.identifier.doi10.3389/fmats.2020.00116por
dc.subject.wosScience & Technologypor
sdum.journalFrontiers in Materialspor
oaire.versionVoRpor
Aparece nas coleções:3B’s - Artigos em revistas/Papers in scientific journals

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
20306-13 Brancato et al Frontiers in Materials 2020.pdf4,4 MBAdobe PDFVer/Abrir

Este trabalho está licenciado sob uma Licença Creative Commons Creative Commons

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID